Search
Now showing items 1-10 of 448
Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.
(The Cochrane Collaboration., 2013)
The primary objective of this review was to evaluate the antiviral efficacy of co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection. The secondary objectives were to evaluate the safety and ...
A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.
(American Society for Microbiology., 2005)
In human immunodeficiency virus type 1 (HIV-1) subtype B infections, the emergence of viruses able to use
CXCR4 as a coreceptor is well documented and associated with accelerated CD4 decline and disease progression.
However, ...
Knowledge and acceptability of HAART among TB patients in Durban, South Africa.
(Taylor & Francis., 2005)
From October 2002 to February 2003, we conducted semi-structured interviews on knowledge of
HIV, antiretroviral treatment, and willingness to participate in voluntary counselling and testing and
HAART with 54 consenting ...
Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate Human Immunodeficiency Virus Type 1 vaccines.
(American Society for Microbiology., 2005)
No abstract available.
Bigotry and oppressive laws in Africa drive HIV in men who have sex with men.
(Plos., 2013)
No abstract available.
Increasing burden of pulmonary tuberculosis in young women.
(South African Medical Association / Health & Medical Publications Group., 2006)
No abstract available.
Utilizing nucleic acid amplification to identify acute HIV infection.
(Lippincott Williams & Wilkins., 2006)
No abstract available.
Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.
(Elsevier., 2011)
Background. Nevirapine given once-daily for the first 6, 14, or 28 weeks of life to infants exposed to HIV-1
via breastfeeding reduces transmission through this route compared with single-dose nevirapine at birth or ...
Immune evaluation of HIV-infected and noninfected pre-eclamptics.
(MedPharm, 2009)
No abstract available.
HIV prevention transformed : the new prevention research agenda.
(Elsevier., 2011)
We have entered a new era in HIV prevention whereby priorities have expanded from biomedical
discovery to include implementation, effectiveness, and the effect of combination prevention at
the population ...